1-3 of 3
Seiichiro Katagiri, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting the Hedgehog Signaling Pathway Limits the Self-Renewal of BCR-ABL1 Positive Leukemia Cells: Molecular Mechanisms

Tetsuzo Tauchi, M.D., Seiichiro Katagiri, M.D., Seiichi Okabe, M.D., Yosuke Minami, MD, PhD, Tomoki Naoe, MD, PhD, Kazuma Ohyashiki, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 531.
https://doi.org/10.1182/blood.V120.21.531.531
Published: 2012
Journal Articles

Combined Effects of a Pan-ABL1 Kinase Inhibitor, Ponatinib and Dasatinib Against T315I Mutant Forms of BCR-ABL1: In Vitro and In Vivo Studies

Tetsuzo Tauchi, M.D., Seiichiro Katagiri, M.D., Seiichi Okabe, M.D., Eishi Ashihara, MD, PhD, Shinya Kimura, MD, PhD, Taira Maekawa, MD, DMSci, Kazuma Ohyashiki, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2482.
https://doi.org/10.1182/blood.V118.21.2482.2482
Published: 2011
Journal Articles

Targeting the Hedgehog Signaling Pathway in Therapy-Resistant BCR-ABL1 Positive Leukemia with Ponatinib

Seiichiro Katagiri, M.D., Tetsuzo Tauchi, M.D., Seiichi Okabe, M.D., Eishi Ashihara, MD, PhD, Shinya Kimura, MD, PhD, Taira Maekawa, MD, DMSci, Kazuma Ohyashiki, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 63.
https://doi.org/10.1182/blood.V118.21.63.63
Published: 2011